Aquestive to Disclose Q4 2025 Results and Pipeline Progress on March 4-5
Aquestive Therapeutics will report Q4 2025 results March 4 and hold investor call March 5, discussing financial performance and pipeline progress including Anaphylm™ development.
AQSTclinical dataearnings report